Latest News in the pharma Industry

Policy & Regulation

Amgen Submits Applications in the US and Europe for Kyprolis (Carfilzomib) for the Treatment of Relapsed Multiple Myeloma

Amgen Submits Applications in the US and Europe for Kyprolis (Carfilzomib) for the Treatment of Relapsed Multiple Myeloma

29 Jan 2015

Read more 
Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic Sivextro

Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic Sivextro

27 Jan 2015

Read more 
pSivida Reports Iluvien Receives Marketing Authorization in Two More EU Countries

pSivida Reports Iluvien Receives Marketing Authorization in Two More EU Countries

27 Jan 2015

Read more 
Impax Receives FDA Approval for a Generic Version of Lamictal Orally Disintegrating Tablets

Impax Receives FDA Approval for a Generic Version of Lamictal Orally Disintegrating Tablets

26 Jan 2015

Read more 
NICE Recommends Xarelto (Rivaroxaban) as an Effective Treatment Option for Reducing Risk of Secondary Events in ACS

NICE Recommends Xarelto (Rivaroxaban) as an Effective Treatment Option for Reducing Risk of Secondary Events in ACS

23 Jan 2015

Read more 
21 CFR Part 11 Compliance for SaaS/Cloud Applications: 2-Day In-Person Seminar

21 CFR Part 11 Compliance for SaaS/Cloud Applications: 2-Day In-Person Seminar

20 Jan 2015

Read more 
Fresenius Kabi Receives FDA Approval for Neostigmine Methylsulfate Injection

Fresenius Kabi Receives FDA Approval for Neostigmine Methylsulfate Injection

20 Jan 2015

Read more 
Regeneron and Sanofi Announce Praluent Marketing Authorization Application has Been Accepted for Review by EMA

Regeneron and Sanofi Announce Praluent Marketing Authorization Application has Been Accepted for Review by EMA

15 Jan 2015

Read more 
Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda

Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda

15 Jan 2015

Read more 
Daiichi Sankyo Receives Approval in Japan for the Manufacture and Marketing of Methemoglobinemia Treatment Methylene Blue Injection 50 mg

Daiichi Sankyo Receives Approval in Japan for the Manufacture and Marketing of Methemoglobinemia Treatment Methylene Blue Injection 50 mg

9 Jan 2015

Read more 
Impax Pharmaceuticals Announces FDA Approval of Rytary Extended-Release Capsules for the Treatment of Parkinson's Disease

Impax Pharmaceuticals Announces FDA Approval of Rytary Extended-Release Capsules for the Treatment of Parkinson's Disease

9 Jan 2015

Read more 
Rx-360 Summary of EMA Guideline on Health Based Exposure Limited in Shared Facilities

Rx-360 Summary of EMA Guideline on Health Based Exposure Limited in Shared Facilities

31 Dec 2014

Read more